Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 38 Records) |
Query Trace: Glioblastoma and BRAF[original query] |
---|
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
IDH1, ATRX, and BRAFV600E mutation in astrocytic tumors and their significance in patient outcome in north Indian population. Surgical neurology international 2018 9 29. Chatterjee Debajyoti, Radotra Bishan Dass, Kumar Narendra, Vasishta Rakesh Kumar, Gupta Sunil Kum |
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations. Acta neuropathologica communications 2018 10 6 (1): 106. Williams Erik A, Miller Julie J, Tummala Shilpa S, Penson Tristan, Iafrate A John, Juratli Tareq A, Cahill Daniel |
Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature. Cancers 2019 Feb 11 (3): . Wojtas Bartosz, Gielniewski Bartlomiej, Wojnicki Kamil, Maleszewska Marta, Mondal Shamba S, Nauman Pawel, Grajkowska Wieslawa, Glass Rainer, Schüller Ulrich, Herold-Mende Christel, Kaminska Boze |
TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors. Neuro-oncology advances 2020 7 2 (1): vdz059. Cantero Diana, Mollejo Manuela, Sepúlveda Juan M, D'Haene Nicky, Gutiérrez-Guamán Myriam J, Rodríguez de Lope Ángel, Fiaño Concepción, Castresana Javier S, Lebrun Laetitia, Rey Juan A, Salmon Isabelle, Meléndez Bárbara, Hernández-Laín Aurel |
TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma. Neuro-oncology advances 2020 11 2 (1): vdaa114. Kikuchi Zensho, Shibahara Ichiyo, Yamaki Tetsu, Yoshioka Ema, Shofuda Tomoko, Ohe Rintaro, Matsuda Ken-Ichiro, Saito Ryuta, Kanamori Masayuki, Kanemura Yonehiro, Kumabe Toshihiro, Tominaga Teiji, Sonoda Yukihi |
Infrequent RAS mutation is not associated with specific histological phenotype in gliomas. BMC cancer 2021 Sep 21 (1): 1025. Makino Yasuhide, Arakawa Yoshiki, Yoshioka Ema, Shofuda Tomoko, Minamiguchi Sachiko, Kawauchi Takeshi, Tanji Masahiro, Kanematsu Daisuke, Nonaka Masahiro, Okita Yoshiko, Kodama Yoshinori, Mano Masayuki, Hirose Takanori, Mineharu Yohei, Miyamoto Susumu, Kanemura Yonehi |
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
Molecular Pathology of Gliomas. Surgical pathology clinics 2021 8 14 (3): 379-386. Galbraith Kristyn, Snuderl Mati |
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features. Brain tumor pathology 2021 7 38 (3): 228-233. Natsumeda Manabu, Chang Michael, Gabdulkhaev Ramil, Takahashi Haruhiko, Tsukamoto Yoshihiro, Kanemaru Yu, Okada Masayasu, Oishi Makoto, Okamoto Kouichirou, Rodriguez Fausto J, Kakita Akiyoshi, Fujii Yukihiko, Schreck Karisa |
BRAF more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAF but without a survival advantage. BMC neurology 2021 May 21 (1): 195. Wang Wei, Wang Maode, Jiang Haitao, Wang Tuo, Da Ro |
A rapid genotyping panel for detection of primary central nervous system lymphoma. Blood 2021 3 138 (5): 382-386. Gupta Mihir, Burns Evan J, Georgantas Nicholas Z, Thierauf Julia, Nayyar Naema, Gordon Amanda, Jones SooAe S, Pisapia Michelle, Sun Ying, Burns Ryan P, Velarde Jose, Jordan Justin T, Frigault Matthew J, Nahed Brian V, Jones Pamela S, Barker Fred G, Curry William T, Gupta Rajiv, Batchelor Tracy T, Romero Javier M, Brastianos Priscilla K, Marble Hetal D, Martinez-Lage Maria, Tateishi Kensuke, Lennerz Jochen K, Dietrich Jorg, Cahill Daniel P, Carter Bob S, Shankar Ganesh |
Genetic signature and treatment of pediatric high-grade glioma. Molecular and clinical oncology 2021 Apr 14 (4): 70. Guidi Milena, Giunti Laura, Buccoliero Anna Maria, Caporalini Chiara, Censullo Maria Luigia, Galli Luisa, Genitori Lorenzo, Sardi Iaco |
SNP-based detection of allelic imbalance: A novel approach for identifying KIAA1549-BRAF fusion in pilocytic astrocytoma using DNA sequencing. Experimental and molecular pathology 2021 2 120 104621. Bobach Ida Schwartz, Stougaard Magn |
BRAF Frequently Co-occurs With IDH1/2, TP53, and ATRX Mutations in Adult Patients With Gliomas and Is Associated With Poorer Survival Than That of Patients Harboring BRAF . Frontiers in oncology 2021 1 10 531968. Da Rong, Wang Maode, Jiang Haitao, Wang Tuo, Wang W |
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma. Journal of cancer research and clinical oncology 2022 8 . Lazaridis Lazaros, Schmidt Teresa, Oster Christoph, Blau Tobias, Pierscianek Daniela, Siveke Jens T, Bauer Sebastian, Schildhaus Hans-Ulrich, Sure Ulrich, Keyvani Kathy, Kleinschnitz Christoph, Stuschke Martin, Herrmann Ken, Deuschl Cornelius, Scheffler Björn, Kebir Sied, Glas Mart |
A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
[Glioblastoma That Does Not Improve with Standard Treatment: Poor Prognostic Factors and Future Perspectives]. Brain and nerve = Shinkei kenkyu no shinpo 2022 5 74 (5): 668-676. Narita Yoshita |
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma. Nature cancer 2021 Dec 2 (12): 1372-1386. Arrieta Víctor A, Chen Andrew X, Kane J Robert, Kang Seong Jae, Kassab Cynthia, Dmello Crismita, Zhao Junfei, Burdett Kirsten B, Upadhyayula Pavan S, Lee-Chang Catalina, Shilati Joseph, Jaishankar Dinesh, Chen Li, Gould Andrew, Zhang Daniel, Yuan Jinzhou, Zhao Wenting, Ling Xiaoyang, Burks Jared K, Laffleur Brice, Amidei Christina, Bruce Jeffrey N, Lukas Rimas V, Yamaguchi Jonathan T, Cieremans David, Rothschild Gerson, Basu Uttiya, McCord Matthew, Brat Daniel J, Zhang Hui, Cooper Lee A D, Zhang Bin, Sims Peter, Cloughesy Tim F, Prins Robert, Canoll Peter, Stupp Roger, Heimberger Amy B, Horbinski Craig, Iwamoto Fabio M, Rabadan Raul, Sonabend Adam |
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta neuropathologica 2022 2 143 (3): 403-414. Pratt Drew, Abdullaev Zied, Papanicolau-Sengos Antonios, Ketchum Courtney, Panneer Selvam Pavalan, Chung Hye-Jung, Lee Ina, Raffeld Mark, Gilbert Mark R, Armstrong Terri S, Pytel Peter, Borys Ewa, Klonoski Joshua M, McCord Matthew, Horbinski Craig, Brat Daniel, Perry Arie, Solomon David, Eberhart Charles, Giannini Caterina, Quezado Martha, Aldape Kenne |
Epithelioid glioblastoma exhibits a heterogeneous molecular feature: A targeted next-generation sequencing study. Frontiers in oncology 2022 12 12 980059. Pan Rui, Wang Xiaotong, Fang Ru, Xia Qiuyuan, Wu Nan, Rao Q |
Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study. Thrombosis research 2022 11 221 10-18. Kapteijn Maaike Y, Kaptein Fleur H J, Stals Milou A M, Klaase Eva E, García-Ortiz Inés, van Eijk Ronald, Ruano Dina, van Duinen Sjoerd G, Cannegieter Suzanne C, Taphoorn Martin J B, Dirven Linda, Koekkoek Johan A F, Klok Frederikus A, Versteeg Henri H, Buijs Jeroen |
Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene. Cancer cell international 2022 1 22 (1): 9. Marei Hany E, Althani Asmaa, Afifi Nahla, Hasan Anwarul, Caceci Thomas, Felsani Armando, Tringali Giuseppe, Cifola Ingrid, Pozzoli Giacomo, Cenciarelli Car |
Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort. JCO precision oncology 2022 1 6 e2100232. Upadhyay Vivek A, Johnson Bruce E, Landman Adam B, Hassett Michael |
Molecular landscape of IDH-wildtype, H3-wildtype glioblastomas of adolescents and young adults (AYA). Neuropathology and applied neurobiology 2022 Feb . Shi Zhi-Feng, Li Kay Ka-Wai, Huang Queenie Jun-Qi, Wang Wei-Wei, Kwan Johnny Sheung-Him, Chen Hong, Liu Xiang-Zhi, Li Wen-Cai, Chan Danny Tat-Ming, Zhang Zhen-Yu, Mao Ying, Ng Ho-Keu |
Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A. Neuropathology : official journal of the Japanese Society of Neuropathology 2023 2 . Leske Henning, Blakstad Hanne, Lund-Iversen Marius, Skovholt Else Kathrine, Niehusmann Pitt, Ramm-Pettersen Jon-Terje, Skogen Karoline, Kongelf Geir, Sprauten Mette, Magelssen Henriette, Brandal Pett |
Integrated molecular and clinical analysis of BRAF-mutant glioma in adults. NPJ precision oncology 2023 2 7 (1): 23. Schreck Karisa C, Langat Pinky, Bhave Varun M, Li Taibo, Woodward Eleanor, Pratilas Christine A, Eberhart Charles G, Bi Wenya Lin |
Druggable genomic landscapes of high-grade gliomas. Frontiers in medicine 2023 12 10 1254955. Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, , Jenna Canzoniero, Stuart A Grossman, Kristen Marrone, Karisa C Schreck, Valsamo Anagnost |
Prognostic Value of BRAF Mutation in Glioblastoma. JPMA. The Journal of the Pakistan Medical Association 2024 1 74 (1): 185-186. Ayesha Sohail, Qurat-Ul-Ain Virani, Hafiza Fatima Aziz, Muhammad Shahzad Sham |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: